Application of human chorionic gonadotropin in preparation of pregnancy assisting medicine for patients with premature ovarian insufficiency
The invention relates to the technical field of pharmacy, in particular to application of human chorionic gonadotropin in preparation of a pregnancy assisting medicine for patients with premature ovarian insufficiency. According to the medicine prepared from the human chorionic gonadotropin, the FSH of a patient is reduced to be smaller than 15 mIU/ml, the LH of the patient is reduced to be smaller than 10 mIU/ml, then 10000U of HCG is injected into the muscle of the patient at a time, dormant follicles can be activated in vivo, and therefore POI patients can obtain offspring with genetic genes of the POI patients, and the medicine has the advantages of being economical, convenient and free of pain..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 01. Okt. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
CHEN XIAO [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-10-01, Last update posted on www.tib.eu: 2022-09-07, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN113456801 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA013463543 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA013463543 | ||
| 003 | DE-627 | ||
| 005 | 20230504142416.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA013463543 | ||
| 035 | |a (EPA)CN113456801 | ||
| 035 | |a (EPA)77884051 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a CHEN XIAO |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of human chorionic gonadotropin in preparation of pregnancy assisting medicine for patients with premature ovarian insufficiency |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-10-01, Last update posted on www.tib.eu: 2022-09-07, Last updated: 2023-02-09 | ||
| 520 | |a The invention relates to the technical field of pharmacy, in particular to application of human chorionic gonadotropin in preparation of a pregnancy assisting medicine for patients with premature ovarian insufficiency. According to the medicine prepared from the human chorionic gonadotropin, the FSH of a patient is reduced to be smaller than 15 mIU/ml, the LH of the patient is reduced to be smaller than 10 mIU/ml, then 10000U of HCG is injected into the muscle of the patient at a time, dormant follicles can be activated in vivo, and therefore POI patients can obtain offspring with genetic genes of the POI patients, and the medicine has the advantages of being economical, convenient and free of pain. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a XU JIAN |4 aut | |
| 700 | 0 | |a YU YUANYUAN |4 aut | |
| 700 | 0 | |a HU YINGYING |4 aut | |
| 700 | 0 | |a LI YOUJIANG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 01. Okt. |
| 773 | 1 | 8 | |g year:2021 |g day:01 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/77884051/publication/CN113456801A1?q=CN113456801 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 01 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 01 |c 10 | ||